Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression

Cytokine

Volumn 9, Issue 11, 1997, Pages 853-858

  Maes, Michael ^a,e   Bosmans, Eugène ^b   De Jongh, Raf ^c   Kenis, Gunther ^b,c   Vandoolaeghe, Eric ^a   Neels, Hugo ^d  

^a Clinical Research Center for Mental Health of Antwerp   (Belgium)

^b Eurogenetics   (Belgium)

^c General Hospital St Jan   (Belgium)

^d Medical Research OCMW   (Belgium)

^e Stuivenberg General Hospital   (Belgium)

Author keywords

Antidepressants; CC16; CD8; Cytokines; Psychoneuroimmunology

Indexed keywords

CD8 ANTIGEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ARTICLE; CLARA CELL; DEPRESSION; HUMAN; LEUKOCYTE; LONG TERM CARE; MOLECULE; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0031282469     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1997.0238     Document Type: Article

References (50)

1. 1. Maes M, Bosmans E, Suy E, Minner B, Raus J (1989) Impaired lymphocyte stimulation by mitogens in severely depressed patients. A complex interface with HPA-axis hyperfunction, noradrenergic activity and the ageing process. Br J Psychiatr 155:793-798.
2. 2. Hickie I, Hickie C, Bennett B, Wakefield D, Silove D, Mitchell P, Lloyd A (1995) Biochemical correlates of in vivo cell-mediated immune dysfunction in patients with depression: a preliminary report. Int J Immunopharmacol 17:685-690.
3. 3. Maes M, Lambrechts J, Bosmans E, Jacobs J, Suy E, Vandervorst C, DeJonckheere C, Minner B, Raus J (1992) Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychol Med 22:45-53.
4. 4. Herbert TB, Cohen S (1993) Depression and immunity: a meta-analytic review. Psychol Bull 113:472-486.
5. 5. Muller N (1995) Psychoneuroimmunology; implications for the drug treatment of psychiatric disorders. CNS Drugs 4:125-140.
6. 6. Perini GI, Zara M, Carraro C, Tosin C, Gava F, Santucci MG, Valverde S, Defranchis G (1995) Psychoimmunoendocrine effects of panic disorder. Hum Psychopharmacol 10:461-465.
7. 7. Duch DS, Woolf JH, Nichol CA, Davidson JR, Garbutt JC (1984) Urinary excretion of biopterin and neopterin in psychiatric disorders. Psychiatr Res 11:83-89.
8. 8. Dunbar PR, Hill J, Neale TJ, Mellsop GW (1992) Neopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophrenia. Psychol Med 22:1051-1057.
9. 9. Maes M, Scharpé S, Meltzer HY, Okayli G, Bosmans E, D'Hondt P, Vanden Bossche B, Cosyns P (1994) Increased neopterin and interferon γ secretion and lower availability of L-tryptophan in major depression: further evidence for activation of cell-mediated immunity. Psychiatr Res 54:143-160.
10. 10. Linnoila M, Whorton R, Rubinow DR, Cowdry RW, Ninan PT, Waters RN (1983) CSF prostaglandin levels in depressed and schizophrenic patients. Arch Gen Psychiatry 40:405-406.
11. 11. Calabrese JR, Skwerer RG, Barna B, Gulledge AD, Valenzuela R, Butkus A, Subichin S, Krupp NE (1986) Depression, immunocompetence, and prostaglandins of the E series. Psychiatr Res 17:41-47.
12. 12. Maes M, Meltzer HY, Bosnians E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R (1995) Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 34:301-309.
13. 13. Maes M, Vandoolaeghe E, Ranjan R, Bosmans E, Van Gastel A, Bergmans R, Desnyder R (1996) Increased serum soluble CD8 or suppressor/cytotoxic antigen concentrations in depression: suppressive effects of glucocorticoids. Biol Psychiatr 40:1273-1282.
14. 14. Nassberger L, Traskman-Bendz L (1993) Increased soluble interleukin-2 receptor concentrations in suicide attempters. Acta Psychiatr Scand 88:48-52.
15. 15. Maes M, Bosmans E, Meltzer HY, Scharpé S, Suy E (1993) Interleukin-1β: A putative mediator of HPA-axis hyperactivity in major depression? Am J Psychiatr 150:1189-1193.
16. 16. Maes M, Scharpé S, Meltzer HY, et al (1993) Relationships between interleukin-6 activity, acute phase proteins and HPA-axis function in severe depression. Psychiatr Res 49:11-27.
17. 17. Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H (1996) Increased CD56+ natural killer cells and related cytokines in major depression. Clin Immunol Immunopathol 78:83-85.
18. 18. Maes M, Vandoolaeghe E, Ranjan R, Bosmans E, Bergmans R, Desnyder R (1995) Increased serum interleukin-1-receptor-antagonist concentrations in major depression. J Affect Disord 36:29-36.
19. 19. Sluzewska A, Rybakowski JK, Laciak M, Mackiewicz A, Sobieska M, Wiktorowiz K (1995) Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann NY Acad Sci 762:474-476.
20. 20. Sluzewska A, Rybakowski JK, Sobieska M, Bosmans E, Pollet H, Wiktorowicz K (1996) Increased levels of alpha-1-acid glycoprotein and interleukin-6 in refractory depression. Depression (in press).
21. 21. Sluzewska A, Rybakowski J, Bosmans E, Sobieska M, Berghmans R, Maes M, Wiktorowicz K (1996) Indicators of immune activation in major depression. Psychiatr Res 64:161-167.
22. 22. Maes M, Vandewoude M, Scharpé S, De Clerck L, Stevens W, Lepoutre L, Schotte C (1991) Anthropometric and biochemical assessment of the nutritional state in depression: evidence for lower visceral protein plasma levels in depression. J Affect Disord 23:25-33.
23. 23. Maes M, Scharpé S, Van Grootel L, Uyttenbroeck W, Cooreman W, Cosyns P, Suy E (1992) Higher α1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness. J Affect Disord 24:183-192.
24. 24. Joyce PR, Hawes CR, Mulder RT, Sellman JD, Wilson DA, Boswell DR (1992) Elevated levels of acute phase plasma proteins in major depression. Biol Psychiatry 32:1035-1041.
25. 25. Maes M, Scharpe S, D'Haese W, De Broe M, Cosyns P (1994) Hypozincaemia in depression. J Affect Disord 31:135-140.
26. 26. Sluzewska A, Rybakowski JK, Sobieska M, Wiktorowicz K (1996) Concentrations and microheterogeneity glycophorms of alpha-1-acid glycoprotein in major depression. J Affect Disord 39:149-155.
27. 27. Song C, Dinan T, Leonard BE (1994) Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. J Affect Disord 30:283-288.
28. 28. Song C, Leonard BE (1994) An acute phase protein response in the olfactory bulbectomized rat: effect of sertraline treatment. Med Sci Res 22:313-314.
29. 29. Sluzewska A, Nowakowska E, Gryska K, Mackiewicz A (1994) Haptoglobin levels in a chronic mild stress model of depression in rats before and after treatment. Eur Neuropharmacol P-1-18:302.
30. 30. Kent S, Bluthé R-M, Kelley KW, Dantzer R (1992) Sickness behavior as a new target for drug development. Trends Psychol Sci 13:24-28.
31. 31. Yirmiya R (1996) Endotoxin produces a depressive-like episode in rats. Brain Res 711:163-174.
32. 32. McDonald EM, Mann AH, Thomas HC (1987) Interferons as mediators of psychiatric morbidity: an investigation in a trial of recombinant α-interferon in hepatitis-B carriers. Lancet 2:1175-1179.
33. 33. Niiranen A, Laaksonen R, Iivanainen M, Mattson K, Fakkila M, Cantell K (1988) Behavioral assessment of patients treated with alpha-interferon. Acta Psychiatrica Scand 78:622-626.
34. 34. Singh G, Katyal SL, Brown WE, Kennedy AL, Singh U, Wong-Chong ML (1990) Clara cell 10 kDa protein (CC10): comparison of structure and function to uteroglobin. Biochim Biophys Acta 1039:348-355.
35. 35. Dierynck I, Bernard A, Roels H, De Ley M (1995) Potent inhibition of both interferon-γ production and biologic activity by the Clara cell protein CC16. Am J Respir Cell Mol Biol 12:205-210.
36. 36. Thase ME, Rush AJ (1995) Treatment-resistant depression. In Bloom FE, Kupfer DJ (eds) Psychopharmacology, the Fourth Generation of Progress, Raven Press, New York, pp. 1081-1098.
37. 37. Maes M, Vandevyvere J, Vandoolaeghe E, Bril T, Vandoolaeghe E, Neels H (1996) Disorders in iron metabolism and the erythron in major depression: further evidence for an inflammatory response. J Affect Disord 40:23-33.
38. 38. Bremner I, Beattie JH (1995) Copper and zinc metabolism in health and disease: speciation and interactions. Proc Nutr Soc 54:489-499.
39. 39. Heinrich PC, Castell JV, Andus T (1990) Review article: interleukin-6 and the acute phase response. Biochem J 265:621-636.
40. 40. Dayer J-M, Burger D (1994) Interleukin-1, tumor necrosis factor and their specific inhibitors. Eur Cytokine Netw 5:563-571.
41. 41. Dinarello CA (1994) The biological properties of interleukin-1. Eur Cytokine Netw 5:517-531.
42. 42. Roux-Lombard P, Modoux C, Dayer JM (1989) Production of interleukin-1 (IL-1) and a specific IL-1 inhibitor during human monocyte-macrophage differentiation: influence of GM-CSF. Cytokine 45-52.
43. 43. Tomkinson BE, Brown MC, Ip SH, Carrabis S, Sullivan JL (1989) Soluble CD8 during T cell activation. J Immunol 142:2230-2236.
44. 44. Kim HS, Degiannis D, Raskova J, Raska K (1991) Cyclosporine A and prednisolone inhibit lectin- and alloantigen-induced release of sCD8: correlation with proliferative responses. Clin Immunol Immunopathol 60:27-39.
45. 45. Maes M, Bosmans E, Ranjan R, Vandoolaeghe E, Meltzer HY, De Ley M, Bergmans R, Stans G, Desnyder R (1996) Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1-receptor-antagonist in schizophrenia. Schizophr Res 21:39-50.
46. 46. American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association, Washington, DC.
47. 47. Spitzer RL, Williams JBW, Gibbon M, First MB (1990) Structured Clinical Interview according to DSM-III-R. American Press, New York.
48. 48. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-61.
49. 49. Zweig MH, Campbell G (1993) Receiver operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39:561-577.
50. 50. Cohen J (1960) A coefficient of agreement for nominal scales. Educat Psycholol Meas 20:37-46.